Blick auf das Washington DC Capitol mit wehender amerikanischer Flagge
Quelle: - ©iStock:
Google
PR Newswire  | 

NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Marex Group plc 37,47 $ Marex Group plc Chart -0,27%
Zugehörige Wertpapiere:

PHILADELPHIA, Nov. 3, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Marex Group plc (NASDAQ: MRX) ("Marex" or the "Company") on behalf of investors who purchased Marex shares during the period of May 16, 2024 through August 5, 2025 (the "Class Period").

Investor Deadline: Investors who purchased or acquired Marex securities during the Class Period may, no later than December 8, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE .

Marex, headquartered in London, provides global financial services including trading, clearing, and risk management.

According to the Complaint, on August 5, 2025, NINGI Research released an extensive report detailing financial improprieties by Marex, including that the Company had engaged in a multi-year accounting scheme involving opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures designed to conceal losses, inflate profits, and mask risk exposure. The report identified numerous multi-million-dollar discrepancies in intercompany receivables and loans across over 56 entities.

It is further alleged that Marex concealed nearly $1 billion in off-balance-sheet derivatives through a Luxembourg fund controlled by the Company, generating non-cash profits and inflating operating cash flow by misclassifying structured note issuance as income.

Following the report, Marex's stock price dropped $2.33, or 6.2%, closing at $35.31 amid heavy trading volume, causing investor losses. 

If you are a Marex investor and would like to learn more about this action, CLICK HERE  or please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865.

About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

For more information or to discuss your rights, please contact:
Andrew Abramowitz
Senior Counsel
Berger Montague
(215) 875-3015
aabramowitz@bergermontague.com

Caitlin Adorni
Director of Portfolio & Institutional Client Monitoring Services
Berger Montague
(267) 764-4865
cadorni@bergermontague.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline-302602195.html

SOURCE Berger Montague


Für dich aus unserer Redaktion zusammengestellt

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend